Adrenergic Receptor Polymorphisms Associated with Resting Heart Rate: The HyperGEN Study

The association between polymorphisms in the β1, β2 and α2B adrenergic receptor (ADR) genes (ADRB1, ADRB2 and ADRA2B) and resting heart rate was examined in white and African‐American participants of the HyperGEN Study. All analyses were adjusted for age, sex, body mass index, alcohol use, smoking status and daily exercise within strata of race, hypertension status and beta‐blocker use. The Ser49Gly polymorphism of the β1 ADR was associated with resting heart rate in hypertensive African‐Americans and hypertensive whites taking beta‐blockers, with carriers of the Gly allele having a higher mean resting heart rate by 2.7 and 4.4 beats per minute (bpm), respectively. The Arg389Gly polymorphism of the β1 ADR was associated with lower heart rate in the normotensive African‐American sample. A β1 haplotype (Ser49Gly‐Arg389Gly) was modestly associated with resting heart rate in the hypertensive African‐Americans. The α2B C/A polymorphism was associated with heart rate in hypertensive whites, and both whites and African‐Americans taking beta‐blockers, with carriers of the A allele having a higher mean resting heart rate. In summary, each of the ADR gene polymorphisms was associated with heart rate in at least one stratum studied, but there was no consistent association from which one would infer a large genetic contribution to heart rate.

[1]  Douglas W. Smith,et al.  Interactive Effects of Common &bgr;2-Adrenoceptor Haplotypes and Age on Susceptibility to Hypertension and Receptor Function , 2005, Hypertension.

[2]  Julie A. Johnson,et al.  β-Adrenergic Receptor Polymorphisms: Cardiovascular Disease Associations and Pharmacogenetics , 2002, Pharmaceutical Research.

[3]  G. Dorn,et al.  β1-adrenergic receptor polymorphisms confer differential function and predisposition to heart failure , 2003, Nature Medicine.

[4]  M. Leppert,et al.  A genome-wide affected sibpair linkage analysis of hypertension: the HyperGEN network. , 2003, American journal of hypertension.

[5]  Eric Boerwinkle,et al.  A meta-analysis of genome-wide linkage scans for hypertension: the National Heart, Lung and Blood Institute Family Blood Pressure Program. , 2003, American journal of hypertension.

[6]  D. Rizzoni,et al.  &bgr;2-Adrenergic Receptor Gene Polymorphism, Age, and Cardiovascular Phenotypes , 2003, Hypertension.

[7]  P. Insel,et al.  Receptor gene polymorphisms: lessons on functional relevance from the β1‐adrenoceptor , 2003, British journal of pharmacology.

[8]  C. Lewis,et al.  Evidence for a gene influencing heart rate on chromosome 4 among hypertensives , 2002, Human Genetics.

[9]  R. Olshen,et al.  A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. , 2002, American journal of human genetics.

[10]  G. Abecasis,et al.  Merlin—rapid analysis of dense genetic maps using sparse gene flow trees , 2002, Nature Genetics.

[11]  B. Lejeune,et al.  Effects of beta1-adrenoceptor genetic polymorphisms on resting hemodynamics in patients undergoing diagnostic testing for ischemia. , 2001, The American journal of cardiology.

[12]  L. Groop,et al.  Polymorphism in the &bgr;1-Adrenergic Receptor Gene and Hypertension , 2001, Circulation.

[13]  A. Aleixandre de Artiñano,et al.  Alpha-adrenoceptor subtypes. , 2001, Pharmacological research.

[14]  K. Köpke,et al.  Novel variants in 3 kb of 5′UTR of the β1‐adrenergic receptor gene (–93C>T, –210C>T, and –2146T>C): –2146C homozygotes present in patients with idiopathic dilated cardiomyopathy and coronary heart disease , 2000, Human mutation.

[15]  M A Province,et al.  NHLBI family blood pressure program: methodology and recruitment in the HyperGEN network. Hypertension genetic epidemiology network. , 2000, Annals of epidemiology.

[16]  E. Boerwinkle,et al.  Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. , 2000, Circulation.

[17]  R. Hetzer,et al.  Beta1-adrenoceptor gene variations: a role in idiopathic dilated cardiomyopathy? , 2000, Journal of molecular medicine.

[18]  M. Hausberg,et al.  The sympathetic nervous system in the pathogenesis of hypertension. , 1999, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[19]  D. Bernstein,et al.  Cardiovascular and Metabolic Alterations in Mice Lacking Both β1- and β2-Adrenergic Receptors* , 1999, The Journal of Biological Chemistry.

[20]  A. Dyer,et al.  Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality: the Chicago Heart Association Detection Project in Industry. , 1999, American journal of epidemiology.

[21]  S Heidenreich,et al.  How to assess glomerular function and damage in humans. , 1999, Journal of hypertension.

[22]  A. Dyer,et al.  Resting heart rate is a risk factor for cardiovascular and noncardiovascular mortality. , 1999 .

[23]  K. Desai,et al.  Alterations in dynamic heart rate control in the β1-adrenergic receptor knockout mouse. , 1998, American journal of physiology. Heart and circulatory physiology.